#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3881216	Functional	Antagonist activity at PGD2 receptor in human platelets assessed as inhibition of PGD2-mediated cAMP accumulation preincubated for 5 mins followed by PGD2 addition measured after 2 mins by HTRF assay	Homo sapiens	79	ALA3880428	assay format	Patent Bioactivity Data
2.	ALA3881218	Functional	Agonist activity at human EP1 receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
3.	ALA3881219	Functional	Agonist activity at human EP1 receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
4.	ALA3881220	Functional	Agonist activity at human EP2 receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
5.	ALA3881221	Functional	Agonist activity at human EP2 receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
6.	ALA3881222	Functional	Agonist activity at human EP3 receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
7.	ALA3881223	Functional	Agonist activity at human EP3 receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
8.	ALA3881224	Functional	Agonist activity at human EP4 receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
9.	ALA3881225	Functional	Agonist activity at human EP4 receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
10.	ALA3881226	Functional	Agonist activity at human FP receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
11.	ALA3881227	Functional	Agonist activity at human FP receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
12.	ALA3881228	Functional	Agonist activity at human TP receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
13.	ALA3881229	Functional	Agonist activity at human TP receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
14.	ALA3881230	Functional	Agonist activity at human IP receptor expressed in HEK293 cells assessed as increase in intracellular calcium flux	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
15.	ALA3881231	Functional	Agonist activity at human IP receptor expressed in HEK293 cells assessed as increase in cAMP production	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
16.	ALA3881232	Binding	Selectivity ratio of IC50 for PGD2 receptor in human platelets to IC50 for human EP1 receptor expressed in HEK293 cells by cAMP accumulation assay	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
17.	ALA3881233	Binding	Selectivity ratio of IC50 for PGD2 receptor in human platelets to IC50 for human EP2 receptor expressed in HEK293 cells by cAMP accumulation assay	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
18.	ALA3881234	Binding	Selectivity ratio of IC50 for PGD2 receptor in human platelets to IC50 for human EP3 receptor expressed in HEK293 cells by cAMP accumulation assay	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
19.	ALA3881235	Binding	Selectivity ratio of IC50 for PGD2 receptor in human platelets to IC50 for human EP4 receptor expressed in HEK293 cells by cAMP accumulation assay	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data
20.	ALA3881236	Binding	Selectivity ratio of IC50 for PGD2 receptor in human platelets to IC50 for human FP receptor expressed in HEK293 cells by cAMP accumulation assay	Homo sapiens	79	ALA3880428	cell-based format	Patent Bioactivity Data